問卷

TPIDB > Principal Investigator

Principal Investigator



更新時間:2025-10-18

梁智瑋
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

6Cases

2025-09-01 - 2029-12-31

Not yet recruiting
A Phase 2, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V540A in Healthy Females 16 to 26 Years of Age
  • Condition/Disease

    Healthy

  • Test Drug

    注射劑 注射劑

Participate Sites
6Sites

Recruiting6Sites

2026-06-01 - 2028-12-31

Phase II

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
9Sites

2025-12-01 - 2029-01-04

Phase II

Active
  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

2026-07-01 - 2033-11-30

Phase III

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

2025-11-01 - 2026-04-30

Phase II

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Terminated4Sites

2025-07-31 - 2028-09-01

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
8Sites

Recruiting8Sites